← FDA Drug Approvals (Drugs@FDA)

LYNPARZA

NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2014-12-19

Drug application

FDA Application #

NDA206162

Application type

New Drug Application

Brand name

LYNPARZA

Generic name

Olaparib

Active ingredients

OLAPARIB

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

ASTRAZENECA

First approval

2014-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown